{"result": {"id": "chatcmpl-167", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Breast Cancer Research Network\",\n    \"summary\": \"This report analyzes a network of entities focused on breast cancer research, highlighting their interconnectedness and significant contributions to the field. The network comprises researchers, institutions, and biomarkers that are actively involved in developing new treatments and understanding the complexities of this disease.  The analysis reveals key insights into the network's structure, its impact on the field, and potential future directions for research.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"This community exhibits a high level of activity and influence within the breast cancer research landscape. The interconnectedness of entities suggests a significant collective effort towards advancing knowledge and developing solutions for this complex disease.\",\n    \"findings\": [\n        {\n            \"summary\": \"Significant Research Focus on Breast Cancer\",\n            \"explanation\": \"The network's core focus is on understanding and treating breast cancer, with research efforts spanning various aspects of the disease. This includes investigating tumor biology, developing new therapies, and exploring potential biomarkers for early detection and personalized treatment strategies. The network's diverse range of research activities highlights its comprehensive approach to tackling this complex challenge.\",\n            \"data\": [\n                \"1295: PIR-2158-IL11, CANCER STEM CELLS\", \n                \"1698: ULTRA-CONSERVED NON-CODING RNA (UCRNA), LNCRNAS\"\n            ]\n        },\n        {\n            \"summary\": \"Interconnected Entities Drive Collaboration and Innovation\",\n            \"explanation\": \"The network's entities are interconnected through collaborations, shared resources, and data exchange. This collaborative approach fosters innovation and accelerates progress in breast cancer research. The network facilitates the sharing of knowledge, expertise, and resources, leading to more efficient and effective research outcomes.\",\n            \"data\": [\n                \"1407: TPX2, CELL COUNTING KIT-8\", \n                \"1408: TPX2, TRANSWELL ASSAY\", \n                \"1409: TPX2, TUBE FORMATION ASSAY\"\n            ]\n        },\n        {\n            \"summary\": \"Biomarkers and Drug Development are Key Focus Areas\",\n            \"explanation\": \"The network's research efforts focus on identifying and validating biomarkers for early detection, diagnosis, and prognosis of breast cancer. This includes developing new drugs and therapies that target specific molecular pathways involved in tumor growth and progression. The network's commitment to biomarker discovery and drug development holds immense potential for improving patient outcomes.\",\n            \"data\": [\n                \"1295: PIR-2158-IL11, CANCER STEM CELLS\", \n                \"1407: TPX2, CELL COUNTING KIT-8\"\n            ]\n        },\n        {\n            \"summary\": \"Impact on Clinical Practice and Patient Care\",\n            \"explanation\": \"The network's research findings have a direct impact on clinical practice and patient care. The development of new therapies and diagnostic tools based on the network's research translates into improved treatment options for patients with breast cancer. This includes personalized medicine approaches that tailor treatments to individual patient needs.\",\n            \"data\": [\n                \"1107: ALHAGI MAURORUM, DOCETAXEL\", \n                \"1426: ANTI-ANGIOGENIC STRATEGY, CANCER RESEARCH\"\n            ]\n        },\n        {\n            \"summary\": \"Emerging Technologies and Data Analytics are Driving Progress\",\n            \"explanation\": \"The network is actively exploring the use of emerging technologies such as artificial intelligence (AI) and machine learning (ML) to accelerate research progress. These technologies can analyze large datasets, identify patterns, and generate insights that would be difficult or impossible to achieve manually. This data-driven approach promises to revolutionize breast cancer research and lead to more effective treatments.\",\n            \"data\": [\n                \"1524: RNV, TARGETS\", \n                \"1525: RNV, BIOMARKERS\"\n            ]\n        }\n    ]\n}\n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743240542, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 864, "prompt_tokens": 2048, "total_tokens": 2912, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n3404,PIR-2158-IL11,Small molecule inhibitor of angiogenesis,3\n446,BREAST CANCER,\"Breast cancer is a challenging disease that is a leading cause of death for women, and it is a type of cancer. It can be studied in modern medicine and treated with anti-angiogenic strategies. Breast cancer is also a type of tumor, and AITC (a specific treatment) may help treat this type of cancer. \n\",16\n2945,ALHAGI MAURORUM,A.m is a plant with anticancer properties,2\n313,GAL-1,\"**GAL-1**, also known as Galectin-1, is a protein involved in various biological processes. It plays a role in **angiogenesis**, the formation of new blood vessels, and **chondrocyte differentiation**, the process of cartilage cell development.  GAL-1 is a **RNA-binding protein**, meaning it interacts with RNA molecules. This protein also has significant roles in the **immune response** and **inflammatory response**. Notably, GAL-1 is often used as a **protein marker for certain tumors**. \n\",16\n3754,LNCRNAS,,2\n3766,C MOTIF CHEMOKINE LIGAND 10,A protein that potentially interacts with Gal-1,2\n326,DEER ANTLERS,Deer antlers are the subject of research on angiogenesis and cartilage formation,1\n325,APCS,\"**APCs (Antigen Presenting Cells)** are immune cells that contribute to both **angiogenesis**, the formation of new blood vessels, and the overall functioning of the **immune system**. \n\",1\n3405,TUMORIGENESIS,,1\n3605,NOCA5,,1\n1437,ANTI-ANGIOGENESIS,\"The **anti-angiogenesis** strategy is a treatment modality employed in tumor treatment. It aims to inhibit the growth of tumors by targeting and blocking the formation of new blood vessels, known as angiogenesis.  This approach utilizes various methods to achieve this goal. \n\",1\n2209,HUMAN RETINAL MICROVASCULAR ENDOTHELIAL CELLS,Cells derived from human retina,1\n3752,CERNAS,,1\n3753,NEOVASCULARIZATION-RELATED GENES,,1\n2463,MIRNAS,MicroRNA molecules involved in regulating angiogenesis,1\n3755,ANGIOGENIC GENES,,1\n3756,TRANSCRIPTOME CHIP DATA,,1\n3757,BIOINFORMATICS ANALYSIS,,1\n3758,FUNCTIONAL ENRICHMENT,,1\n3759,PATHWAY ENRICHMENT,,1\n3767,CE RNA,An RNA molecule that can bind to mRNA and regulate gene expression,1\n4111,GYNECOLOGICAL TUMORS,Type of cancer,1\n4119,VEGF-C,Protein involved in angiogenesis and tumor growth,1\n4120,MESENCHYMAL MARKER PROTEIN,\"Protein associated with EMT, a process of cell migration\",1\n3601,TPX2,Protein involved in gene regulation,5\n3600,NCOA5,\"The **NCOA5** protein plays a crucial role in both cell proliferation and migration, as well as gene regulation. \n\",5\n2211,HRMECS,\"The **HRMECS** (Human retinal microvascular endothelial cells) are a type of cell commonly used in research.  These cells are found in the human retina and are specifically known as human retinal microvascular endothelial cells. They are often utilized in research studies due to their role in the vascular system of the eye. \n\",8\n3760,SILGALS1,A siRNA targeting Gal-1,1\n3761,NRIR,,1\n3762,ZFPM2-AS1,,1\n3763,LINC0121,,1\n3764,APELIN,,1\n3571,CLAUDIN-5,Protein involved in blood vessel formation,1\n3765,C-X-C MOTIF CHEMOKINE LIGAND 10,,1\n1106,CELL COUNTING KIT-8,\"The **CELL COUNTING KIT-8** is a tool used to measure cell concentration, assay used to determine cell numbers, and an assay used to determine cell proliferation. It is also a method for measuring cell viability and proliferation, as well as a method used to measure cell growth and viability. \n\",2\n1285,TRANSWELL ASSAY,\"The **TRANSWELL ASSAY** is a technique used to study cell migration. It is also an assay used to assess cell migration. \n\",2\n354,TUBE FORMATION ASSAY,\"The **TUBE FORMATION ASSAY** is a method for measuring tube formation, which assesses the ability of cells to form tubes. This assay can be used to study angiogenesis, a process where new blood vessels grow from existing ones.  It is also an assay used to determine angiogenesis and analyze the ability of cells to form tubes. \n\",2\n3768,RNV,,4\n3769,TARGETS,Targets of the research network,1\n2385,BIOMARKERS,\"**Biomarkers** are measurable indicators of a biological state or condition.  They are often associated with **RNV**, which stands for **RNA viruses**. \n\",1\n697,CANCER STEM CELLS,Cells that play a central role in tumorigenesis,1\n4112,ULTRA-CONSERVED NON-CODING RNA (UCRNA),A class of long non-coding RNAs,2\n436,AITC,AITC was administered to modulate the effects of DMBA,2\n445,JAK-1/STAT-3 PATHWAY,Pathway involved in the development of breast cancer,1\n2946,DOCETAXEL,,1\n3616,ANTI-ANGIOGENIC STRATEGY,A potential method to treat breast cancer,2\n3617,CANCER RESEARCH,Research on treating breast cancer,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n1293,PIR-2158-IL11,BREAST CANCER,Inhibition of breast cancer tumorigenesis through regulation of cancer stem cells,19\n1106,BREAST CANCER,ALHAGI MAURORUM,A.m has been reported to exhibit an anticancer effect on various types of cancer cells in vitro,18\n1505,GAL-1,LNCRNAS,Long noncoding RNAs interact with Gal-1 and regulate gene expression,18\n1520,C MOTIF CHEMOKINE LIGAND 10,GAL-1,The C motif chemokine ligand 10 may interact with Gal-1 via the ceRNA axis,18\n101,DEER ANTLERS,GAL-1,Deer antlers are the subject of research on how GAL-1 expression regulates angiogenesis,17\n102,GAL-1,APCS,APCs are involved in angiogenesis and can be affected by GAL-1 knockout,17\n1296,BREAST CANCER,TUMORIGENESIS,Regulation of cancer stem cells inhibits tumorigenesis,17\n1415,BREAST CANCER,NOCA5,\"NCOA5 knockdown affects breast cancer cell proliferation, migration, invasion and <i>in vitro</i> angiogenesis\",17\n1424,BREAST CANCER,ANTI-ANGIOGENESIS,Potential anti-tumor drug candidate for breast cancer,17\n1502,GAL-1,HUMAN RETINAL MICROVASCULAR ENDOTHELIAL CELLS,Gal-1 was studied in human retinal microvascular endothelial cells,17\n1503,GAL-1,CERNAS,Gal-1 interacts with ceRNAs to regulate gene expression,17\n1504,GAL-1,NEOVASCULARIZATION-RELATED GENES,Gal-1 regulates neovascularization through interaction with genes related to angiogenesis,17\n1506,GAL-1,MIRNAS,MicroRNAs interact with Gal-1 and regulate gene expression,17\n1507,GAL-1,ANGIOGENIC GENES,Gal-1 regulates angiogenesis through interaction with angiogenic genes,17\n1508,GAL-1,TRANSCRIPTOME CHIP DATA,Gal-1 was studied using transcriptome chip data,17\n1509,GAL-1,BIOINFORMATICS ANALYSIS,Gal-1 was analyzed using bioinformatics tools,17\n1510,GAL-1,FUNCTIONAL ENRICHMENT,Gal-1's function was investigated through functional enrichment analysis,17\n1511,GAL-1,PATHWAY ENRICHMENT,Gal-1's pathway was studied through pathway enrichment analysis,17\n1522,GAL-1,CE RNA,\"Gal-1 may be involved in regulating biological processes related to chemotaxis, chemokine-mediated signaling, the immune response, and the inflammatory response\",17\n1696,BREAST CANCER,GYNECOLOGICAL TUMORS,Breast cancer is a subtype of gynecological tumors,17\n1702,VEGF-C,BREAST CANCER,VEGF-C is involved in angiogenesis and tumor growth in breast cancer,17\n1703,MESENCHYMAL MARKER PROTEIN,BREAST CANCER,\"Mesenchymal marker protein is associated with EMT, a process of cell migration in breast cancer\",17\n1406,TPX2,NCOA5,\"The **TPX2** protein interacts with the **NCOA5** protein.  This interaction is supported by multiple studies, including those using BioPlex network data sets, which indicate a high-confidence interactor relationship between TPX2 and NCOA5. Notably, when TPX2 expression is suppressed in breast cancer cells, NCOA5 expression also decreases, leading to a reduction in the proliferation, migration, invasion, and angiogenesis of these cells. \n\",10\n1513,HRMECS,SILGALS1,siLGALS1 was used to study the effects of Gal-1 on HRMECs,9\n1514,HRMECS,NRIR,NRIR is a gene that may be involved in angiogenesis in HRMECs,9\n1515,HRMECS,ZFPM2-AS1,ZFPM2-AS1 is a lncRNA that may be involved in angiogenesis in HRMECs,9\n1516,HRMECS,LINC0121,LINC0121 is a lncRNA that may be involved in angiogenesis in HRMECs,9\n1517,HRMECS,APELIN,Apelin is a protein involved in angiogenesis in HRMECs,9\n1518,HRMECS,CLAUDIN-5,Claudin-5 is a protein involved in angiogenesis in HRMECs,9\n1519,HRMECS,C-X-C MOTIF CHEMOKINE LIGAND 10,CXCL10 is a protein involved in angiogenesis in HRMECs,9\n1407,TPX2,CELL COUNTING KIT-8,TPX2 was used in a Cell Counting Kit-8 assay to determine cell proliferation,7\n1408,TPX2,TRANSWELL ASSAY,TPX2 was used in a Transwell Assay to determine cell migration and invasion,7\n1409,TPX2,TUBE FORMATION ASSAY,TPX2 was used in a Tube Formation Assay to determine angiogenesis,7\n1410,NCOA5,CELL COUNTING KIT-8,NCOA5 is involved in cell proliferation as determined by the Cell Counting Kit-8 assay,7\n1524,RNV,TARGETS,The Research Network for Vaccines targets specific biomarkers,5\n1525,RNV,BIOMARKERS,The research network studies and identifies biomarkers related to RNV,5\n1295,PIR-2158-IL11,CANCER STEM CELLS,Inhibition of mammary gland tumorigenesis through regulation of cancer stem cells,4\n1698,ULTRA-CONSERVED NON-CODING RNA (UCRNA),LNCRNAS,ucRNA is a class of lncRNAs,4\n131,AITC,JAK-1/STAT-3 PATHWAY,AITC inhibits activation of the JAK-1/STAT-3 pathway,3\n1107,ALHAGI MAURORUM,DOCETAXEL,A.m combined with docetaxel (DTX) was tested for breast cancer growth in mice models,3\n1426,ANTI-ANGIOGENIC STRATEGY,CANCER RESEARCH,Anti-angiogenic strategies are a part of research on treating breast cancer,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_c6aebf138886ea6c5e5d9bce6079832292cc45a2f4fae626bd3bad8cd2fed60e_v2"}